395 results
Page 2 of 20
8-K
EX-1.1
x7z66fj
6 Apr 21
Entry into a Material Definitive Agreement
4:02pm
424B5
ffqoeiru3vz
2 Apr 21
Prospectus supplement for primary offering
4:13pm
424B5
f4orx20
31 Mar 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
ec94vezsc sg9uhqd2
17 Mar 21
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results
4:08pm
424B5
hqdoc1guf vv
15 Jan 21
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
qvva ewu5iytt
10 Nov 20
CTI BioPharma Reports Third Quarter 2020 Financial Results
4:15pm
8-K
EX-99.1
4y9p8f3t1dbv
29 Sep 20
Other Events
4:49pm
8-K
EX-99.1
h9h97o4au19yw5 pxf0
6 Aug 20
CTI BioPharma Reports Second Quarter 2020 Financial Results
4:13pm
8-K
EX-99.1
ne87dwqn
7 May 20
CTI BioPharma Reports First Quarter 2020 Financial Results
4:05pm
8-K
9fjzitfvowhna
22 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
EX-99.1
ut9qhjyev4lzqxyi
12 Mar 20
CTI BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm
424B5
imzxicj
14 Feb 20
Prospectus supplement for primary offering
8:14am
8-K
EX-99.1
g9dllwbyj31emis
3 Feb 20
Regulation FD Disclosure
6:17am